BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27472197)

  • 1. Local Intramedullary Delivery of Vancomycin Can Prevent the Development of Long Bone Staphylococcus aureus Infection.
    Loc-Carrillo C; Wang C; Canden A; Burr M; Agarwal J
    PLoS One; 2016; 11(7):e0160187. PubMed ID: 27472197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis with vancomycin-loaded VK100 silicone cement: An experimental study in rats.
    Neyisci C; Erdem Y; Bilekli AB; Demiralp B; Kose O; Bek D; Korkusuz F; Kankilic B
    J Orthop Surg (Hong Kong); 2018; 26(1):2309499017754093. PubMed ID: 29382296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of Tedizolid in Methicillin-Resistant Staphylococcus aureus Experimental Foreign Body-Associated Osteomyelitis.
    Park KH; Greenwood-Quaintance KE; Mandrekar J; Patel R
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6568-6572. PubMed ID: 27550347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Vergidis P; Schmidt-Malan SM; Mandrekar JN; Steckelberg JM; Patel R
    J Infect; 2015 Jun; 70(6):609-15. PubMed ID: 25576292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone.
    Albayati ZA; Sunkara M; Schmidt-Malan SM; Karau MJ; Morris AJ; Steckelberg JM; Patel R; Breen PJ; Smeltzer MS; Taylor KG; Merten KE; Pierce WM; Crooks PA
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1865-8. PubMed ID: 26666918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
    Lefebvre M; Jacqueline C; Amador G; Le Mabecque V; Miegeville A; Potel G; Caillon J; Asseray N
    Int J Antimicrob Agents; 2010 Dec; 36(6):542-4. PubMed ID: 20851576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model.
    Yin LY; Lazzarini L; Li F; Stevens CM; Calhoun JH
    J Antimicrob Chemother; 2005 Jun; 55(6):995-1002. PubMed ID: 15857944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis.
    Rouse MS; Piper KE; Jacobson M; Jacofsky DJ; Steckelberg JM; Patel R
    J Antimicrob Chemother; 2006 Feb; 57(2):301-5. PubMed ID: 16361330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA
    Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats.
    Poeppl W; Lingscheid T; Bernitzky D; Schwarze UY; Donath O; Perkmann T; Kozakowski N; Plasenzotti R; Reznicek G; Burgmann H
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5111-6. PubMed ID: 24936591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress of different drug delivery route of vancomycin for the treatment of chronic osteomyelitis].
    Long YZ; Zhu ZX; Yu Y; Zhang SM
    Zhonghua Wai Ke Za Zhi; 2016 Sep; 54(9):716-20. PubMed ID: 27587217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo assessment of the antimicrobial activity of a calcium-deficient apatite vancomycin drug delivery system in a methicillin-resistant Staphylococcus aureus rabbit osteomyelitis experimental model.
    Amador G; Gautier H; Le Mabecque V; Miegeville AF; Potel G; Bouler JM; Weiss P; Caillon J; Jacqueline C
    Antimicrob Agents Chemother; 2010 Feb; 54(2):950-2. PubMed ID: 19933800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
    Yin LY; Calhoun JH; Thomas TS; Wirtz ED
    J Antimicrob Chemother; 2009 Feb; 63(2):357-60. PubMed ID: 19060292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exebacase in Addition to Daptomycin Is More Active than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats.
    Karau MJ; Schmidt-Malan SM; Yan Q; Greenwood-Quaintance KE; Mandrekar J; Lehoux D; Schuch R; Cassino C; Patel R
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustainable release of vancomycin from micro-arc oxidised 3D-printed porous Ti6Al4V for treating methicillin-resistant Staphylococcus aureus bone infection and enhancing osteogenesis in a rabbit tibia osteomyelitis model.
    Zhang T; Wei Q; Zhou H; Zhou W; Fan D; Lin X; Jing Z; Cai H; Cheng Y; Liu X; Li W; Song C; Tian Y; Xu N; Zheng Y; Liu Z
    Biomater Sci; 2020 Jun; 8(11):3106-3115. PubMed ID: 32350485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres.
    Cevher E; Orhan Z; Mülazimoğlu L; Sensoy D; Alper M; Yildiz A; Ozsoy Y
    Int J Pharm; 2006 Jul; 317(2):127-35. PubMed ID: 16624509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite.
    Shirtliff ME; Calhoun JH; Mader JT
    Clin Orthop Relat Res; 2002 Aug; (401):239-47. PubMed ID: 12151901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone penetrance of locally administered vancomycin powder in a rat femur fracture model.
    Working ZM; Frederiksen H; Drew A; Loc-Carrillo C; Kubiak EN
    Injury; 2017 Jul; 48(7):1459-1465. PubMed ID: 28456368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local delivery of vancomycin for the prophylaxis of prosthetic device-related infections.
    Chilukuri DM; Shah JC
    Pharm Res; 2005 Apr; 22(4):563-72. PubMed ID: 15846464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose bone pharmacokinetics of vancomycin in a porcine implant-associated osteomyelitis model.
    Bue M; Hanberg P; Koch J; Jensen LK; Lundorff M; Aalbaek B; Jensen HE; Søballe K; Tøttrup M
    J Orthop Res; 2018 Apr; 36(4):1093-1098. PubMed ID: 29058823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.